The presence of germline loss‐of‐function variants in BRCA1 or BRCA2 confers a predisposition for breast cancer (absolute risk of 60%–85%) and ovarian cancer (absolute risk of 15%–40%).10 This evidence concerns the gene BRCA1 and ovarian carcinoma.